Maize is one of the most economically important crops globally and much effort has been spent generating the high quality B73 reference genome. However, the 10 chromosome, 2.3 gigabase (Gb) B73 reference genome was a substantial challenge due to the fact it is comprised of 85% transposable elements, 75% of which are long terminal […]
Clinical trials involving probiotics are failing to report on the safety and harms of these treatments.
The “Born in Guangzhou Cohort Study” is looking to recruit 50,000 baby-mother sets by 2020. Since 2012, 1.6 million samples have been collected for the project and the some of the first findings have been published.
A report has highlighted the potential misuses of synthetic biology for biological warfare with recommendations of how we might prepare for and prevent biological attacks.
A mechanism enabling cells to bind and isolate toxic substances could have significant implications for how tumours develop resistance to certain types of chemotherapy.
A new approach to killing C. difficile that silences key bacterial genes while sparing other bacteria may provide a new way to treat the most common hospital-acquired bacterial infection in the US.
Microbiotica has entered into a multi-year strategic collaboration with Genentech, a Roche company, to discover, develop, and commercialise biomarkers, targets, and medicines for inflammatory bowel disease.
Open access dataset reveals how factors such as diet, antibiotics and mental health status can influence the microbial and molecular makeup of your gut.
While some people are warning about artificial intelligence leading to killer robots, researchers are showing the positive impact of A.I. in its potential to overcome disease.
Researchers at the Broad Institute of MIT and Harvard have reported that their platform, SHERLOCK, now can be used to detect viruses directly in clinical samples such as blood or saliva.
E. coli bacteria are the frequent culprits behind outbreaks of food-borne illnesses. But not all strains are harmful; some are even helpful.
As a post-antibiotic future beckons, how can humanity protect itself against the proliferation of superbugs? Research suggests ‘drug sanctuaries’ in hospitals could be a promising solution.